Mechelen, België; 3 september 2024, 22:01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) heeft een kennisgeving van belangrijke deelneming ontvangen van FMR LLC. Overeenkomstig de Belgische transparantiewetgeving1, heeft …
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (TSX: PGIC; PGIC.PR.A) Premium Global Income Split Corp. has declared monthly distributions payable on September 27, 2024 to shareholders of record on September 16, 2024 in the following amounts per share: Share …
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (TSX: CBNK) Mulvihill Canadian Bank Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on October 4, 2024 to unitholders of record on September 27, 2024. For …
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (TSX: XLVE) Mulvihill U.S. Health Care Enhanced Yield ETF has declared a monthly cash distribution in the amount of $0.058333 per unit, payable on October 4, 2024 to unitholders of record on September 27, 2024. …
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (TSX: MPY) Mulvihill Premium Yield Fund has declared a monthly cash distribution for its ETF Class in the amount of $0.05417 per unit, payable on October 4, 2024 to unitholders of record on September 27, 2024. …
Highlights of the second quarter include: Revenue of $299.9 million, an increase of 23% compared to $243.5 million in Q2 FY24. Net income of $35.8 million, compared to $10.6 million in Q2 FY24, with non-GAAP net income of $76.3 million, an increase of 67% …
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference: H.C. …
WESTLAKE VILLAGE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, Chairman and CEO, will discuss clinical-stage programs, recent …
LIFT-AD trial did not meet primary endpoint of GST and key secondary endpoints of cognition (ADAS-Cog11) and function (ADCS-ADL23) In pre-specified subgroups of patients with moderate Alzheimer’s disease or who are APOE4 carriers, fosgonimeton showed a …
After 25 years, the epic KK Wilde is making their comeback with their all-new single "Hellraisers & Vampires" SAN ANTONIO, TX, UNITED STATES, September 3, 2024 /EINPresswire.com/ -- Sometimes it takes a while for the music-loving public to …
NAGOYA, AICHI, JAPAN, September 3, 2024 /EINPresswire.com/ -- airKitchen, the cooking class booking platform, is pleased to announce that the total number of cooking classes in Thailand and Vietnam has surpassed 100. This milestone reflects airKitchen…
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Bank Of Montreal (“BoM” or “the Company”) (NYSE: BMO). Investors who purchased BoM …
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sandbridge Acquisition Corporation (“Sandbridge”), which merged with Owlet, Inc. (“ …
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Verve Therapeutics, Inc. (“Verve …
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Endeavour Silver Corporation (“Endeavour” or “the Company”) (NYSE: EXK). Investors who …
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA). Investors who purchased Mynaric …
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MaxLinear, Inc (“MaxLinear” or “the Company”) (NASDAQ: MXL). Investors who purchased …
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against XPEL, Inc. (“XPEL” or “the Company”) ( …
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against lululemon athletica inc. (“lululemon” or “ …
NEWTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s …
01 days 08:04:38
